Smead Capital Management 13F: Adds $24M to Zoetis (ZTS) Stake
Smead Capital Management increased its position in Zoetis Inc. by 28.2%, now holding over 1.58 million shares valued at approximately $110.4 million.
Reviewed by automated data checks against the source filing. How we make and check alerts
Smead Capital Management added 347,786 shares to its stake in Zoetis Inc. ($ZTS), a 28.20% increase, according to a 13F filing with the SEC dated October 16, 2026. It reported 1,580,996 shares worth $110.40 million at the end of the quarter.
Find the original: Smead Capital Management 13F filings on SEC EDGAR
ZTS
Zoetis Inc.
Key Points
- Smead Capital Management added 347,786 shares of Zoetis Inc. (ZTS), bringing its total holdings to 1,580,996 shares worth about $110.4 million as of October 16, 2026.
- Currently trading around $78.96, Zoetis is below its 52-week high of $148.30, and analysts have given it a 'buy' consensus with a mean target price of $93.47.
- Notably, the company has a P/E ratio of 12.73 and a dividend yield of 2.7%, making it attractive for income-focused investors.
Get $ZTS trade alerts by text
We text you when insiders, Congress or big funds trade $ZTS. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Zoetis Inc. alert may contain errors. Disclosures
Smead Capital Management has boosted its position in Zoetis Inc. (NYSE: ZTS) with a filing on October 16, 2026. The firm added 347,786 shares, increasing its stake by 28.2% to a total of 1,580,996 shares, valued at approximately $110.4 million.
What Changed in Smead Capital Management's Zoetis Position
This increase reflects Smead Capital's confidence in Zoetis as an investment, as the firm has now raised its holdings significantly. Prior to this filing, Smead held 1,232,210 shares, and the addition marks an important step in the fund's strategy.
Other Institutional Activity in Zoetis
Several other institutional investors have shown interest in Zoetis. Blackrock Inc. grew its holdings by 3,846,587 shares, ending with 39,430,181 shares worth about $3.13 billion. State Street Corporation added 343,963 shares to reach 19,667,723 shares, valued at approximately $1.56 billion. Meanwhile, both Vanguard Capital Management LLC and Vanguard Portfolio Management LLC slightly reduced their stakes in the company.
Zoetis Inc. Stock Up 4.9%
As of October 16, Zoetis shares were recently traded around $78.96. This price is below its 50-day moving average of $73.86 but above its 52-week low of $68.77. The stock is currently below its 200-day moving average, which sits at $96.34, and is also well below its 52-week high of $148.30.
Recent Earnings
Zoetis reported trailing twelve-month revenue of approximately $9.53 billion. The company has a net margin of 27.7% and a return on equity of 64.9%. Its next earnings report is set for November 5, 2026, which investors will be closely watching.
Analysts Set New Price Targets
On October 16, 2026, Goldman Sachs initiated coverage of Zoetis with a neutral rating and a price target of $74.00. Citigroup maintained a buy rating with a target of $96.00, while BNP Paribas kept its outperform rating with a target of $110.00. Overall, the consensus among analysts is positive, with a mean target price of about $93.47 based on 15 opinions.
About Zoetis
Zoetis Inc. is a leading animal health company that develops and manufactures medicines, vaccines, and diagnostic products for pets and livestock. The firm operates in a crucial sector, providing health solutions to various animal species, which positions it well within the healthcare industry.
Bottom Line
Smead Capital Management's recent filing shows a clear intent to strengthen its investment in Zoetis. Investors should look out for the upcoming earnings report on November 5, 2026, as well as any further institutional movements that may influence the stock's performance in the market. Remember, this filing reflects the fund's positions as of the reporting period and may not represent current holdings.
Related Filing Alerts
Source: Smead Capital Management's 13F filing on $ZTS (Oct 16, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Smead Capital Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts